HK Stock MarketDetailed Quotes

03692 HANSOH PHARMA

Watchlist
  • 19.120
  • +0.040+0.21%
Not Open Nov 28 16:08 CST
113.49BMarket Cap21.98P/E (TTM)

HANSOH PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
44.21%6.51B
7.69%10.1B
1.73%4.51B
-5.56%9.38B
0.75%4.43B
14.33%9.94B
10.60%4.4B
0.09%8.69B
-13.48%3.98B
12.44%8.68B
Operating income
44.21%6.51B
7.69%10.1B
1.73%4.51B
-5.56%9.38B
0.75%4.43B
14.33%9.94B
10.60%4.4B
0.09%8.69B
-13.48%3.98B
12.44%8.68B
Cost of sales
-8.17%-579.22M
-18.90%-1.03B
-34.34%-535.46M
0.35%-867.01M
4.11%-398.58M
-8.54%-870.04M
-16.16%-415.68M
-9.87%-801.56M
6.30%-357.87M
-20.97%-729.54M
Operating expenses
-8.17%-579.22M
-18.90%-1.03B
-34.34%-535.46M
0.35%-867.01M
4.11%-398.58M
-8.54%-870.04M
-16.16%-415.68M
-9.87%-801.56M
6.30%-357.87M
-20.97%-729.54M
Gross profit
49.06%5.93B
6.55%9.07B
-1.49%3.98B
-6.06%8.52B
1.25%4.04B
14.91%9.07B
10.06%3.99B
-0.81%7.89B
-14.13%3.62B
11.72%7.95B
Selling expenses
-3.06%-1.72B
0.54%-3.53B
0.79%-1.67B
-3.57%-3.55B
-10.05%-1.68B
-10.47%-3.43B
-5.65%-1.53B
5.00%-3.1B
20.04%-1.45B
-1.80%-3.27B
Administrative expenses
-7.25%-353.9M
-18.81%-709.84M
-12.85%-329.96M
36.67%-597.46M
32.43%-292.39M
-24.36%-943.42M
-24.13%-432.69M
2.45%-758.64M
10.34%-348.57M
1.58%-777.69M
Research and development expenses
-28.72%-1.2B
-23.84%-2.1B
-25.77%-929.48M
5.77%-1.69B
-7.59%-739.04M
-43.50%-1.8B
-44.20%-686.93M
-11.74%-1.25B
14.60%-476.38M
-27.16%-1.12B
Special items of operating profit
2.14%462.93M
230.53%1.1B
141.57%453.21M
-27.16%332.17M
-10.66%187.61M
40.96%456.05M
45.51%210M
52.27%323.53M
70.32%144.32M
202.35%212.47M
Operating profit
107.90%3.12B
27.48%3.83B
-0.61%1.5B
-10.33%3.01B
-2.45%1.51B
8.22%3.35B
3.58%1.55B
3.24%3.1B
-3.35%1.49B
29.95%3B
Financing cost
----
-14.68%-66.68M
----
-10.08%-58.14M
----
---52.82M
----
----
----
----
Earning before tax
107.90%3.12B
27.73%3.77B
-0.61%1.5B
-10.66%2.95B
-2.45%1.51B
6.51%3.3B
3.58%1.55B
3.24%3.1B
-3.35%1.49B
29.95%3B
Tax
-86.06%-392.66M
-33.99%-488.65M
0.05%-211.04M
37.89%-364.68M
17.67%-211.15M
-10.92%-587.18M
5.63%-256.47M
-19.18%-529.39M
-9.00%-271.76M
-9.33%-444.18M
After-tax profit from continuing operations
111.47%2.73B
26.85%3.28B
-0.70%1.29B
-4.76%2.58B
0.57%1.3B
5.61%2.71B
5.63%1.29B
0.48%2.57B
-5.73%1.22B
34.35%2.56B
Earning after tax
111.47%2.73B
26.85%3.28B
-0.70%1.29B
-4.76%2.58B
0.57%1.3B
5.61%2.71B
5.63%1.29B
0.48%2.57B
-5.73%1.22B
34.35%2.56B
Profit attributable to shareholders
111.47%2.73B
26.85%3.28B
-0.70%1.29B
-4.76%2.58B
0.57%1.3B
5.61%2.71B
5.63%1.29B
0.48%2.57B
-5.73%1.22B
34.35%2.56B
Basic earnings per share
109.09%0.46
25.00%0.55
0.00%0.22
-4.35%0.44
0.00%0.22
4.55%0.46
4.76%0.22
-6.38%0.44
-16.00%0.21
23.68%0.47
Diluted earnings per share
109.09%0.46
18.18%0.52
0.00%0.22
0.00%0.44
10.00%0.22
0.00%0.44
-4.76%0.2
-6.38%0.44
-16.00%0.21
23.68%0.47
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 44.21%6.51B7.69%10.1B1.73%4.51B-5.56%9.38B0.75%4.43B14.33%9.94B10.60%4.4B0.09%8.69B-13.48%3.98B12.44%8.68B
Operating income 44.21%6.51B7.69%10.1B1.73%4.51B-5.56%9.38B0.75%4.43B14.33%9.94B10.60%4.4B0.09%8.69B-13.48%3.98B12.44%8.68B
Cost of sales -8.17%-579.22M-18.90%-1.03B-34.34%-535.46M0.35%-867.01M4.11%-398.58M-8.54%-870.04M-16.16%-415.68M-9.87%-801.56M6.30%-357.87M-20.97%-729.54M
Operating expenses -8.17%-579.22M-18.90%-1.03B-34.34%-535.46M0.35%-867.01M4.11%-398.58M-8.54%-870.04M-16.16%-415.68M-9.87%-801.56M6.30%-357.87M-20.97%-729.54M
Gross profit 49.06%5.93B6.55%9.07B-1.49%3.98B-6.06%8.52B1.25%4.04B14.91%9.07B10.06%3.99B-0.81%7.89B-14.13%3.62B11.72%7.95B
Selling expenses -3.06%-1.72B0.54%-3.53B0.79%-1.67B-3.57%-3.55B-10.05%-1.68B-10.47%-3.43B-5.65%-1.53B5.00%-3.1B20.04%-1.45B-1.80%-3.27B
Administrative expenses -7.25%-353.9M-18.81%-709.84M-12.85%-329.96M36.67%-597.46M32.43%-292.39M-24.36%-943.42M-24.13%-432.69M2.45%-758.64M10.34%-348.57M1.58%-777.69M
Research and development expenses -28.72%-1.2B-23.84%-2.1B-25.77%-929.48M5.77%-1.69B-7.59%-739.04M-43.50%-1.8B-44.20%-686.93M-11.74%-1.25B14.60%-476.38M-27.16%-1.12B
Special items of operating profit 2.14%462.93M230.53%1.1B141.57%453.21M-27.16%332.17M-10.66%187.61M40.96%456.05M45.51%210M52.27%323.53M70.32%144.32M202.35%212.47M
Operating profit 107.90%3.12B27.48%3.83B-0.61%1.5B-10.33%3.01B-2.45%1.51B8.22%3.35B3.58%1.55B3.24%3.1B-3.35%1.49B29.95%3B
Financing cost -----14.68%-66.68M-----10.08%-58.14M-------52.82M----------------
Earning before tax 107.90%3.12B27.73%3.77B-0.61%1.5B-10.66%2.95B-2.45%1.51B6.51%3.3B3.58%1.55B3.24%3.1B-3.35%1.49B29.95%3B
Tax -86.06%-392.66M-33.99%-488.65M0.05%-211.04M37.89%-364.68M17.67%-211.15M-10.92%-587.18M5.63%-256.47M-19.18%-529.39M-9.00%-271.76M-9.33%-444.18M
After-tax profit from continuing operations 111.47%2.73B26.85%3.28B-0.70%1.29B-4.76%2.58B0.57%1.3B5.61%2.71B5.63%1.29B0.48%2.57B-5.73%1.22B34.35%2.56B
Earning after tax 111.47%2.73B26.85%3.28B-0.70%1.29B-4.76%2.58B0.57%1.3B5.61%2.71B5.63%1.29B0.48%2.57B-5.73%1.22B34.35%2.56B
Profit attributable to shareholders 111.47%2.73B26.85%3.28B-0.70%1.29B-4.76%2.58B0.57%1.3B5.61%2.71B5.63%1.29B0.48%2.57B-5.73%1.22B34.35%2.56B
Basic earnings per share 109.09%0.4625.00%0.550.00%0.22-4.35%0.440.00%0.224.55%0.464.76%0.22-6.38%0.44-16.00%0.2123.68%0.47
Diluted earnings per share 109.09%0.4618.18%0.520.00%0.220.00%0.4410.00%0.220.00%0.44-4.76%0.2-6.38%0.44-16.00%0.2123.68%0.47
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data